<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="2229">
  <stage>Registered</stage>
  <submitdate>15/01/2009</submitdate>
  <approvaldate>15/01/2009</approvaldate>
  <nctid>NCT00825123</nctid>
  <trial_identification>
    <studytitle>Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals</studytitle>
    <scientifictitle>The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>141/07 bayside health</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Central Arterial Pressure</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Ivabradine
Treatment: drugs - Metoprolol
Treatment: drugs - Placebo

Experimental: Ivabradine - 

Active Comparator: Metoprolol - 

Placebo Comparator: Placebo - 


Treatment: drugs: Ivabradine
Ivabradine 10 mg once

Treatment: drugs: Metoprolol
Metoprolol 50 mg once

Treatment: drugs: Placebo
Lactose powder

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>central arterial pressure</outcome>
      <timepoint>baseline and 4 hours post treatment</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy volunteers:

          -  aged 18 - 25 years OR

          -  aged &gt;60 years</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>85</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>-  Chronic disease

          -  Unable to give informed consent

          -  Treated or untreated systemic arterial hypertension (SBP &gt;160mmHg and/or DBP &gt; 90mmHg)

          -  Resting bradycardia (heart rate &lt; 60 beats/minute)

          -  Pregnancy or active lactation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Basic Science</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>The people receiving the treatment/s</masking1>
    <masking2>The people administering the treatment/s</masking2>
    <masking3 />
    <masking4>The people analysing the results/data</masking4>
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Withdrawn</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2012</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>The Alfred Hospital - Melbourne</hospital>
    <postcode>3004 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Bayside Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this project is to determine the effects of slowing heart rate upon both
      central and peripheral blood pressures using Ivabradine. The effects of Ivabradine will be
      compared to Metoprolol and placebo.

      Participants will attend the hospital for 3 visits where they will be randomised to receive
      either Ivabradine, Metoprolol and placebo on each visit. Non-invasive measures of blood
      pressure will be recorded before and after consuming the study drug.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00825123</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Bronwyn A Kingwell, PhD</name>
      <address>Baker IDI Hearte &amp; Diabetes Institute</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>